NueHealth names new CEO, COO and CFO in leadership overhaul

NueHealth announced a leadership transition July 7, 2026, naming founder Daniel R. Tasset as CEO and elevating Whitney Courser and CJ Kadel to top operating and finance roles. The moves are aimed at speeding ambulatory surgery center growth, expanding provider risk-based payment models and strengthening the company’s national specialty care platform.

Why it matters: - NueHealth is reshaping its top leadership as it pushes harder into ambulatory surgery center growth and value-based care. - The changes are meant to support physician-led specialty care, operational integration and provider risk-based payment models. - The company is also expanding its presence in new markets while deepening partnerships with physicians and health systems.

What happened: - NueHealth announced a strategic leadership transition and executive promotions on July 7, 2026. - Daniel R. Tasset, the company’s founder and current executive chairman, will become chief executive officer and executive chairman. - Michael Sheerin retired on June 30, 2026, after leading the company through a period of growth and transformation. - Sheerin will move to NueHealth’s Board of Advisors and continue providing strategic guidance. - Whitney Courser was promoted to chief operating officer. - CJ Kadel was promoted to chief financial officer. - NueHealth also appointed Lisa Dutterer as senior vice president.

The details: - Tasset founded NueHealth in 1997 with a focus on physician-centered healthcare organizations that could deliver higher-quality care at lower cost. - Sheerin previously served as senior vice president at Rothman Orthopaedics. - Sheerin also spent more than 15 years with the University of Pennsylvania Health System overseeing hospital operations, physician practice management and service line growth. - Courser has been with NueHealth since 2003. - Courser has held roles across finance, operations, business development and executive management. - Courser helped lead ambulatory surgery center partnerships, specialty hospital ventures and healthcare real estate initiatives. - Kadel previously held finance leadership roles at C2FO and PwC. - Kadel’s background includes financial operations, capital strategy and complex reporting environments. - Dutterer is based in Pennsylvania. - Dutterer brings experience in healthcare operations, physician partnerships and strategic growth across hospitals, ambulatory care settings and integrated healthcare organizations. - NueHealth has significant physician and health system partnerships in Pennsylvania and New Jersey, including collaborations with Rothman Orthopaedics and other healthcare organizations. - NueHealth is headquartered in Leawood, Kansas. - The company specializes in developing, managing and performing ambulatory surgery centers and advancing value-based care. - NueHealth partners with physicians, health systems and payors using operating standards and proprietary technology. - The company says those capabilities help align clinical performance with financial accountability across different markets and partnership structures.

Between the lines: - The executive changes suggest NueHealth is trying to connect investment, operations and care delivery more tightly as the company scales. - Tasset’s return to the CEO role signals a renewed emphasis on the founder’s original physician-centered strategy. - Promoting leaders with finance, operations and partnership backgrounds points to a growth plan that depends on execution as much as expansion. - The focus on downside risk models shows NueHealth is positioning for a healthcare environment that rewards accountability and cost discipline.

What's next: - NueHealth expects the new leadership team to support continued national expansion. - The company plans to deepen physician partnerships and broaden capabilities for providers taking substantial downside risk. - Courser will oversee enterprise operations and strategic growth initiatives in her expanded role. - Kadel will lead enterprise financial strategy and capital planning. - Dutterer will support growth in the Mid-Atlantic region. - The company is aiming to deliver sustainable long-term value through disciplined investment and infrastructure support.

The bottom line: - NueHealth is betting that a founder-led reset and broader executive bench will help accelerate ASC growth, strengthen value-based care and sharpen its provider-risk strategy.